Cargando…

Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?

Pancreatic cancer (PC) remains one of the deadliest malignancies worldwide. Chemoresistance is a significant clinical problem in pancreatic ductal adenocarcinoma (PDAC) and numerous potential mechanisms have been demonstrated but much remains to be understood. To overcome the existing limitations in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Wenhao, Yang, Gang, Qiu, Jiangdong, Luan, Jingyang, Zhang, Ying, You, Lei, Feng, Mengyu, Zhao, Fangyu, Liu, Yueze, Cao, Zhe, Zheng, Lianfang, Zhang, Taiping, Zhao, Yupei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797580/ https://www.ncbi.nlm.nih.gov/pubmed/31475468 http://dx.doi.org/10.1002/cam4.2384

Ejemplares similares

Expression, function and clinical application of stanniocalcin‐1 in cancer
por: Zhao, Fangyu, et al.
Publicado: (2020)

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
por: Fu, Yibo, et al.
Publicado: (2021)

Novel Discoveries Targeting Pathogenic Gut Microbes and New Therapies in Pancreatic Cancer: Does Pathogenic E. coli Infection Cause Pancreatic Cancer Progression Modulated by TUBB/Rho/ROCK Signaling Pathway? A Bioinformatic Analysis
por: Luo, Wenhao, et al.
Publicado: (2020)

Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
por: Qiu, Jiangdong, et al.
Publicado: (2018)

Role of the microbiome in occurrence, development and treatment of pancreatic cancer
por: Wang, Yicheng, et al.
Publicado: (2019)

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
por: Feng, Mengyu, et al.
Publicado: (2018)

Is Invagination Anastomosis More Effective in Reducing Clinically Relevant Pancreatic Fistula for Soft Pancreas After Pancreaticoduodenectomy Under Novel Fistula Criteria: A Systematic Review and Meta-Analysis
por: Cao, Zhe, et al.
Publicado: (2020)

Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory
por: Luo, Wenhao, et al.
Publicado: (2020)

PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathway
por: Qiu, Jiangdong, et al.
Publicado: (2023)

MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
por: Cao, Zhe, et al.
Publicado: (2020)

Targeting hypoxic tumor microenvironment in pancreatic cancer
por: Tao, Jinxin, et al.
Publicado: (2021)

Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer
por: Xiong, Guangbing, et al.
Publicado: (2019)

MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Xiong, Guangbing, et al.
Publicado: (2018)

Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma
por: de Jong, Evelien J. M., et al.
Publicado: (2021)

Correction to: MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Xiong, Guangbing, et al.
Publicado: (2021)

Identification of chemoresistance‐related mRNAs based on gemcitabine‐resistant pancreatic cancer cell lines
por: Zhou, Jiarong, et al.
Publicado: (2019)

Novel therapies targeting hypoxia mechanism to treat pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2021)

Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2012)

Cancer-specific survival and metastasis in pancreatic mucinous cystadenocarcinoma: A SEER-based cohort study
por: Wang, Ruobing, et al.
Publicado: (2022)

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
por: Wang, Jian‐Hua, et al.
Publicado: (2019)

Lifestyle interventions can reduce the risk of Barrett’s esophagus: a systematic review and meta‐analysis of 62 studies involving 250,157 participants
por: Zhao, Zhanwei, et al.
Publicado: (2021)

Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2021)

Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study
por: Liu, Jiaqing, et al.
Publicado: (2019)

Performance of cervical cancer screening and triage strategies among women living with HIV in China
por: Duan, Rufei, et al.
Publicado: (2021)

Chinese and global burdens of gastric cancer from 1990 to 2019
por: He, Yuxin, et al.
Publicado: (2021)

A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
por: Jo, Jung Hyun, et al.
Publicado: (2022)

Comorbidity, lifestyle factors, and sexual satisfaction among Chinese cancer survivors
por: Wang, Jingya, et al.
Publicado: (2021)

Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207
por: You, Lei, et al.
Publicado: (2018)

Significant variations in the cervical cancer screening rate in China by individual‐level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset
por: Bao, Heling, et al.
Publicado: (2018)

PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis
por: Sun, Hongru, et al.
Publicado: (2019)

Trends in incidence and associated risk factors of suicide mortality in patients with non‐small cell lung cancer
por: Zhou, Huaqiang, et al.
Publicado: (2018)

FOLFIRINOX or gemcitabine/nab‐paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision‐making in real‐world
por: Marschner, Norbert, et al.
Publicado: (2022)

Regional and racial disparity in proximal gastric cancer survival outcomes 1996–2016: Results from SEER and China National Cancer Center database
por: Zhao, Lulu, et al.
Publicado: (2021)

Hope and challenge: Precision medicine in bladder cancer
por: Su, Hongwei, et al.
Publicado: (2019)

Effectiveness of endoscopic gastric cancer screening in a rural area of Linzhou, China: results from a case–control study
por: Chen, Qiong, et al.
Publicado: (2016)

A retrospective observational study of intraductal breast papilloma and its coexisting lesions: A real‐world experience
por: Li, Xiaona, et al.
Publicado: (2020)

Fine‐mapping of HLA class I and class II genes identified two independent novel variants associated with nasopharyngeal carcinoma susceptibility
por: Wang, Tong‐Min, et al.
Publicado: (2018)

Association of peripheral blood leukocyte KIBRA methylation with gastric cancer risk: a case–control study
por: Zhang, Yan, et al.
Publicado: (2018)

Methylation of three genes encoded by X chromosome in blood leukocytes and colorectal cancer risk
por: Tian, Tian, et al.
Publicado: (2021)

MiR‐634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf‐ERK signaling pathway
por: Tan, Zhigang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6fqkiqdkqd4cf8ioglc9udttop